# Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

> **NCT00545558** · PHASE1 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 18 (actual)

## Conditions studied

- Hepatitis C
- HIV Infections

## Interventions

- **DRUG:** Efavirenz
- **DRUG:** Emtricitabine/Tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT00545558
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545558, "Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00545558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*